Language Impairment May Be More Common Than Previously Thought in Perinatally HIV-Infected Children, Study Suggests

Please note: These files can be quite large. Allow some time for them to download.

There's nothing like hearing the results of studies directly from those who actually conducted the research. In this interview, you'll meet one of these impressive HIV researchers and read her explanation of a study she presented at CROI 2009.

My name is Mabel Rice; I'm from the University of Kansas. The title of our poster is "Language Impairment in 7- to 16-Year-Old Perinatally HIV-Infected Children." This is a study that's taking a look at a broad set of issues known as HAND, or HIV-associated neurocognitive disorders. In particular, we're interested in children's language acquisition. It's a part of cortical functioning that can be affected: The language can be affected [directly], or broader cognitive processes can be affected that, in turn, drive the language impairment.

Mabel Rice, Ph.D.

There are two things we have that are unusual for this kind of work. One of them is that we have direct assessment of hearing, and we know that some of the children that were identified as being language impaired are children who have a hearing deficit, which is very important. Mitochondrial RNA is related to the risk of hearing impairments with these kids; we're able to document that. We're also able to document that there's a greater-than-expected risk for language impairment [among perinatally HIV-infected children]. These youngsters are trailing their typically developing peers in language acquisition by a considerable extent. We looked at children who scored in the bottom percentile, roughly, on an omnibus language measure. Then we looked to see the extent to which they had other cognitive problems.

Advertisement

How many children were you looking at?

We had 178. These are children that were perinatally exposed [to HIV] and are HIV positive. Out of those 178, about 33% score low on language assessments. When you subdivide that, about two-thirds of those are youngsters who have cognitive impairment as well. There's a higher risk than we would expect for children to be delayed in language acquisition, even if they are not cognitively impaired.

Then we took a look at disease indicators, and found that those who were cognitively impaired as well were more likely to have these disease indicators: a CDC [U.S. Centers for Disease Control and Prevention] Class C event at entry into the study; a higher viral load; or a lower percentage of CD4 cells available to fight the disease.

The import of all of this is that the kids who are more at risk for these disease indicators are kids who have more pervasive, higher cognitive risk as well. We have to keep our eye on these kids who are just language-impaired.

One of the predictors was having been on protease inhibitor [PI] treatment at study entry [with an odds ratio of approximately 4.0; P = .07 in a multivariate analysis].

It's about 73% African American. We have done more detailed analyses of race as a risk indicator. These analyses indicate that that risk is significant when we look at secondary language impairment versus no impairment -- that is, the more severe, more extensive cognitive impairment, plus language impairment, is where that predictor variable becomes significant.

We have follow-up analyses planned on that, and we have a follow-up group coming along right behind this group [to examine] children who are HIV negative even though they were also perinatally exposed. We'll be able to compare that group with the [children who became] HIV positive out of perinatal exposure, to help sort through some of these other predictor variables as well.

The predictor is quite strong for the secondary impairment -- a P level about .07 for secondary impairment versus no impairment. It makes quite a difference, actually.

OK. Thank you very much.

You're very welcome. It's my pleasure. This is my first time at this meeting. My major line of work involves kids with language impairment who are not carrying any other known disease state, so this is a natural complement. I've really enjoyed it.

(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Beforeadding your comment, please read TheBody.com's Comment Policy.)

Please do not modify the following input field.

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.